Fractures, particularly hip fractures, are known to cause pain, disability and even increased mortality.Studies, including ...

Celltrion USA launches 2 denosumab biosimilars, Stoboclo and Osenvelt, enhancing treatment options for osteoporosis and ...

“With osteoporosis, or bone loss, weight-bearing is one of the best ways to be able to combat it. So we’re here from Planet ...

Addressing the very real risk to men's health which is often overlooked, Dr Paul Lewis - an interventional radiologist at ...

The Leni and Peter W. May Department of Orthopedic Surgery at the Icahn School of Medicine at Mount Sinai has implemented the ...

Treatment with romosozumab is linked to improved BMD and a reduced risk for vertebral fractures among postmenopausal women with osteoporosis.

The #1 Early Sign of Osteoporosis Most People Miss, According to Orthopedists first appeared on Parade on Jul 3, 2025 This ...

The company estimated that more than 1000 women in Scotland at very high risk of fracture would be eligible for treatment.

Standard first-line drug therapies for the treatment of bone density disorders have been linked to higher risk of experiencing a cardiovascular event, according to a study published June 26 in Epic ...

Biocon Biologics Ltd received UK approval for Vevzuo and Evfraxy, biosimilars of Denosumab. Vevzuo is approved for ...